Author

T. G. Graham

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

A. W. Roberts· 1 shared C. C. Ward· 1 shared C. Dugast-Darzacq· 1 shared D. Dovala· 1 shared D. M. Fines· 1 shared D. M. Fox· 1 shared D. Nomura· 1 shared E. Van Dis· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. W. Roberts

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

p300 Is an Obligate Integrator of Combinatorial Transcription Factor Inputs

J. J. Ferrie, J. P. Karr, T. G. Graham, G. M. Dailey, G. Zhang, R. Tjian, X. Darzacq

This study shows p300 requires multiple transcription factor interaction domains for chromatin binding and catalytic regulation, highlighting the necessity of combinatorial TF inputs for coactivator function.

bioRxiv · May 18, 2023Biophysics

Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2

S. B. Biering, E. Van Dis, E. Wehri, L. H. Yamashiro, X. Nguyenla, C. Dugast-Darzacq, T. G. Graham, J. R. Stroumza, G. R. Golovkine, A. W. Roberts, D. M. Fines, J. N. Spradlin, C. C. Ward, T. Bajaj, D. Dovala, , S. A. Stanley

This study screens FDA-approved compounds for antiviral activity against SARS-CoV-2 and identifies 13 effective compounds, including seven new candidates and one synergistic combination with remdesivir.

bioRxiv · Dec 30, 2020Microbiology